Core Insights - The "Xiansheng Full Exploration Plan" was launched by Xiansheng Pharmaceutical, which will invest 2 billion yuan over the next five years to focus on ten major scientific challenges in the fields of neurology and oncology [1][2] - The plan aims to support disruptive innovation research from the ground up, with a scientific advisory committee composed of 11 academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering [1] Group 1: Investment and Collaboration - Xiansheng Pharmaceutical will invest 2 billion yuan, and the Nanjing Jiangbei New Area will match this with an additional 2 billion yuan, creating a total investment of 4 billion yuan for the "Xiansheng Full Exploration Plan" [2] - The collaboration aims to establish a demonstration project that integrates technological innovation and industrial innovation [2] Group 2: Research Directions - The ten research directions supported by the plan include: 1. Treatment methods to fundamentally reverse the high mortality and disability rates of strokes 2. Discovery, validation, and drug development of potential targets for precise treatment of neurodegenerative diseases 3. Discovery, validation, and drug development of targets (or combinations) that could significantly improve current cancer treatment efficacy 4. Clinical applications of new-generation gene editing technologies 5. Therapeutic applications of RNA interference/mRNA technologies in neurodegenerative diseases, tumors, and infections 6. Clinical applications of new-generation cell therapies 7. Clinical applications of new-generation delivery technologies 8. Clinical applications related to anti-aging mechanisms 9. Application of AI technologies in target discovery and validation based on clinical data 10. Application of AI technologies in predicting clinical efficacy and safety in drug development [1] Group 3: Event Highlights - The meeting attracted two Nobel Prize winners, six academicians from the Chinese Academy of Sciences and the Chinese Academy of Engineering, and nearly 700 leaders from top hospitals and research institutions across the country [2] - The theme of the meeting was "With You, We Dare to Go Far," focusing on collaborative innovation strategies for the Chinese pharmaceutical industry [2]
先声药业将5年投入20亿元支持颠覆性创新